1. Market Research
  2. > Palau Pharma, S.A. - Product Pipeline Review - 2013

Palau Pharma, S.A. - Product Pipeline Review - 2013

  • July 2013
  • -
  • Global Markets Direct
  • -
  • 36 pages

Palau Pharma, S.A. - Product Pipeline Review - 2013

Summary

Global Markets Direct’s pharmaceuticals report, “Palau Pharma, S.A. - Product Pipeline Review - 2013” provides data on the Palau Pharma, S.A.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Palau Pharma, S.A.’s corporate website, SEC filings, investor presentations and featured press releases, both from Palau Pharma, S.A. and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- Palau Pharma, S.A. - Brief Palau Pharma, S.A. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Palau Pharma, S.A. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Palau Pharma, S.A. with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Palau Pharma, S.A.’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate Palau Pharma, S.A.’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Palau Pharma, S.A. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Palau Pharma, S.A.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Palau Pharma, S.A..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Palau Pharma, S.A. and identify potential opportunities in those areas.

Table Of Contents

Palau Pharma, S.A. - Product Pipeline Review - 2013
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Palau Pharma, S.A. Snapshot 5
Palau Pharma, S.A. Overview 5
Key Information 5
Key Facts 5
Palau Pharma, S.A. - Research and Development Overview 6
Key Therapeutic Areas 6
Palau Pharma, S.A. - Pipeline Review 9
Pipeline Products by Stage of Development 9
Pipeline Products - Monotherapy 10
Palau Pharma, S.A. - Pipeline Products Glance 11
Palau Pharma, S.A. - Late Stage Pipeline 11
Phase III Products/Combination Treatment Modalities 11
Palau Pharma, S.A. Clinical Stage Pipeline Products 12
Phase II Products/Combination Treatment Modalities 12
Phase I Products/Combination Treatment Modalities 13
Palau Pharma, S.A. - Early Stage Pipeline Products 14
Preclinical Products/Combination Treatment Modalities 14
Discovery Products/Combination Treatment Modalities 15
Palau Pharma, S.A. - Drug Profiles 16
albaconazole 16
Product Description 16
Mechanism of Action 16
RandD Progress 16
Dendria Project 17
Product Description 17
Mechanism of Action 17
RandD Progress 17
dersalazine 18
Product Description 18
Mechanism of Action 18
RandD Progress 18
Jak3/Syk Dual Inhibitor 19
Product Description 19
Mechanism of Action 19
RandD Progress 19
Neogenius Project 20
Product Description 20
Mechanism of Action 20
RandD Progress 20
UR-13870 21
Product Description 21
Mechanism of Action 21
RandD Progress 21
UR-63325 22
Product Description 22
Mechanism of Action 22
RandD Progress 22
UR-65318 23
Product Description 23
Mechanism of Action 23
RandD Progress 23
UR-67767 24
Product Description 24
Mechanism of Action 24
RandD Progress 24
Palau Pharma, S.A. - Pipeline Analysis 25
Palau Pharma, S.A. - Pipeline Products by Therapeutic Class 25
Palau Pharma, S.A. - Pipeline Products By Target 27
Palau Pharma, S.A. - Pipeline Products by Route of Administration 28
Palau Pharma, S.A. - Pipeline Products By Mechanism of Action 29
Palau Pharma, S.A. - Recent Pipeline Updates 31
Palau Pharma, S.A. - Dormant Projects 33
Palau Pharma, S.A. - Locations And Subsidiaries 34
Head Office 34
Appendix 35
Methodology 35
Coverage 35
Secondary Research 35
Primary Research 35
Expert Panel Validation 35
Contact Us 36
Disclaimer 36

List of Tables

Palau Pharma, S.A., Key Information 5
Palau Pharma, S.A., Key Facts 5
Palau Pharma, S.A. - Pipeline by Indication, 2013 8
Palau Pharma, S.A. - Pipeline by Stage of Development, 2013 9
Palau Pharma, S.A. - Monotherapy Products in Pipeline, 2013 10
Palau Pharma, S.A. - Phase III, 2013 11
Palau Pharma, S.A. - Phase II, 2013 12
Palau Pharma, S.A. - Phase I, 2013 13
Palau Pharma, S.A. - Preclinical, 2013 14
Palau Pharma, S.A. - Discovery, 2013 15
Palau Pharma, S.A. - Pipeline By Therapeutic Class, 2013 26
Palau Pharma, S.A. - Pipeline By Target, 2013 27
Palau Pharma, S.A. - Pipeline By Route of Administration, 2013 28
Palau Pharma, S.A. - Pipeline Products By Mechanism of Action, 2013 30
Palau Pharma, S.A. - Recent Pipeline Updates, 2013 31
Palau Pharma, S.A. - Dormant Developmental Projects,2013 33

List of Figures

Palau Pharma, S.A. - Pipeline by Indication, 2013 7
Palau Pharma, S.A. - Pipeline by Stage of Development, 2013 9
Palau Pharma, S.A. - Monotherapy Products in Pipeline, 2013 10
Palau Pharma, S.A. - Pipeline By Therapeutic Class, 2013 25
Palau Pharma, S.A. - Pipeline Products By Mechanism of Action, 2013 29

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

ref:plp2013

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.